U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07391982) titled 'Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions' on Oct. 02, 2025.
Brief Summary: The goal of this clinical trial is to find out whether lowering the radiation dose to parts of the prostate without visible tumor on MRI can reduce side effects while still effectively treating prostate cancer in men with low or intermediate-risk prostate cancer.
The main questions it aims to answer are:
* Does reducing the radiation dose to healthy prostate tissue lower the risk of bowel and urinary side effects?
* Can we maintain good cancer control by keeping a high dose for MRI-visible tumor areas?
Researchers will...